stella
beta
Mogamulizumab + Low-Dose Total Skin Electron Beam Tx in Mycosis Fungoides & Sézary Syndrome — Stella
Recruiting
Back to Sezary Syndrome trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(1 site)
United States
Stanford Cancer Center, Stanford, California
View full record on ClinicalTrials.gov